Safety, Pharmacokinetic, and Antitumor Activity of SU11248, a Novel Oral Multitarget Tyrosine Kinase Inhibitor, in Patients With Cancer von FAIVRE, Sandrine, DELBALDO, Catherine, ARMAND, Jean-Pierre, SCIGALLA, Paul, RAYMOND, Eric, VERA, Karina, ROBERT, Caroline, LOZAHIC, Stéphanie, LASSAU, Nathalie, BELLO, Carlo, DEPRIMO, Samuel, BREGA, Nicoletta, MASSIMINI, Giorgio

Volltext

Molecular targeting: targeting angiogenesis in solid tumors von Soria, J.-C., Fayette, J., Armand, J.-P.

Volltext

Safety and Pharmacokinetics of Escalated Doses of Weekly Intravenous Infusion of CCI-779, a Novel mTOR Inhibitor, in Patients With Cancer von Raymond, Eric, Alexandre, Jérôme, Faivre, Sandrine, Vera, Karina, Materman, Eric, Boni, Joseph, Leister, Cathie, Korth-Bradley, Joan, Hanauske, Axel, Armand, Jean-Pierre

Volltext

Cutaneous side-effects of kinase inhibitors and blocking antibodies von Robert, Caroline, Soria, Jean-Charles, Spatz, Alain, Le Cesne, Axel, Malka, David, Pautier, Patricia, Wechsler, Janine, Lhomme, Catherine, Escudier, Bernard, Boige, Valérie, Armand, Jean-Pierre, Le Chevalier, Thierry

Volltext

Nasopharyngeal carcinomas: an update von Spano, J.-P., Busson, P., Atlan, D., Bourhis, J., Pignon, J.-P., Esteban, C., Armand, J.-P.

Volltext

Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy von Raymond, E, Faivre, S, Armand, J P

Volltext

Use of angiogenesis inhibitors in tumour treatment von Fayette, Jérôme, Soria, Jean-Charles, Armand, Jean-Pierre

Volltext

Phase I and Pharmacokinetic Study of Aplidine, a New Marine Cyclodepsipeptide in Patients With Advanced Malignancies von FAIVRE, Sandrine, CHLEZE, Stéphame, LOPEZ MARTIN, José Antonio, RAYMOND, Eric, DELBALDO, Catherine, ADY-VAGO, Nora, GUZMAN, Cecilia, LOPEZ-LAZARO, Luis, LOZAHIC, Stéphanie, JIMENO, José, PICO, Fernando, ARMAND, Jean Pierre

Volltext

Long-Term Disease-Free Survivors in Metastatic Undifferentiated Carcinoma of Nasopharyngeal Type von FANDI, A, BACHOUCHI, M, AZLI, N, TAAMMA, A, BOUSSEN, H, WIBAULT, P, ESCHWEGE, F, ARMAND, J.-P, SIMON, J, CVITKOVIC, E

Volltext

Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients von DE CREVOISIER, R, BOURHIS, J, MARANDAS, P, ARMAND, J. P, SCHWAAB, G, LUBOINSKI, B, ESCHWEGE, F, DOMENGE, C, WIBAULT, P, KOSCIELNY, S, LUSINCHI, A, MAMELLE, G, JANOT, F, JULIERON, M, LERIDANT, A. M

Volltext

Multicentre phase II study and pharmacokinetic analysis of irinotecan in chemotherapy-naive patients with glioblastoma von RAYMOND, E, FABBRO, M, VERMILLET, L, ARMAND, J. P, BOIGE, V, RIXE, O, FRENAY, M, VASSAL, G, FAIVRE, S, SICARD, E, GERMA, C, RODIER, J. M

Volltext

Dosage Adjustment and Pharmacokinetic Profile of Irinotecan in Cancer Patients With Hepatic Dysfunction von Raymond, Eric, Boige, Valérie, Faivre, Sandrine, Sanderink, Ger-Jan, Rixe, Olivier, Vernillet, Laurent, Jacques, Christian, Gatineau, Michel, Ducreux, Michel, Armand, Jean-Pierre

Volltext

Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin von Ducreux, M., Rougier, P., Fandi, A., Clavero-Fabri, M.-C., Villing, A.-L., Fassone, F., Fandi, L., Zarba, J., Armand, J.-P.

Volltext

Phase I–II and pharmacokinetic study of gemcitabine combined with oxaliplatin in patients with advanced non-small-cell lung cancer and ovarian carcinoma von Faivre, S., Le Chevalier, T., Monnerat, C., Lokiec, F., Novello, S., Taieb, J., Pautier, P., Lhommé, C., Ruffié, P., Kayitalire, L., Armand, J.-P., Raymond, E.

Volltext

Tyrosine kinase inhibition and grey hair von Robert, Caroline, Spatz, Alain, Faivre, Sandrine, Armand, Jean-Pierre, Raymond, Eric

Volltext

Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck von Pivot, X, Raymond, E, Laguerre, B, Degardin, M, Cals, L, Armand, J P, Lefebvre, J L, Gedouin, D, Ripoche, V, Kayitalire, L, Niyikiza, C, Johnson, R, Latz, J, Schneider, M

Volltext

A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma von Rougier, P., Adenis, A., Ducreux, M., de Forni, M., Bonneterre, J., Dembak, M., Clouet, P., Lebecq, A., Baille, P., Lefresne-Soulas, F., Blanc, C., Armand, J.P.

Volltext

Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I/II trials von RIVORY, L. P, HAAZ, M.-C, CANAL, P, LOKIEC, F, ARMAND, J.-P, ROBERT, J

Volltext

Irinotecan (CPT-11) High-Dose Escalation Using Intensive High-Dose Loperamide to Control Diarrhea von Abigerges, Dany, Armand, Jean-Pierre, Chabot, Guy G., Costa, Ligia Da, Fadel, Elie, Cote, Carole, Hérait, Patrice, Gandia, Daniel

Volltext

Irinotecan Combined With Bolus Fluorouracil, Continuous Infusion Fluorouracil, and High-Dose Leucovorin Every Two Weeks (LV5FU2 Regimen): A Clinical Dose-Finding and Pharmacokineti... von DUCREUX, M, YCHOU, M, SEITZ, J.-F, BONNAY, M, BEXON, A, ARMAND, J.-P, MAHJOUBI, M, MERY-MIGNARD, D, ROUGIER, P

Volltext